CenturyLink Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

CenturyLink Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,805	Closed	-$626K	–	254
2016 Q3	$626K	Buy	+3,805	New	+$600K	0.21%	154
2016 Q1	–	Sell	-2,092	Closed	-$312K	–	287
2015 Q4	$312K	Buy	2,092 +1,017	+95%	+$172K	0.11%	200
2015 Q3	$178K	Buy	1,075 +178	+20%	+$39.2K	0.06%	221
2015 Q2	$217K	Buy	+897	New	+$239K	0.07%	222
2014 Q4	–	Sell	-2,689	Closed	-$636K	–	268
2014 Q3	$636K	Buy	2,689 +1,040	+63%	+$265K	0.22%	161
2014 Q2	$390K	Buy	1,649 +1,018	+161%	+$268K	0.12%	190
2014 Q1	$208K	Buy	+631	New	+$213K	0.07%	218

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

CenturyLink Investment Management's ICPT Position: Q4 2016 in Review

CenturyLink Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 3,805 shares — an estimated $626K sold.

CenturyLink Investment Management first reported a position in ICPT in Q1 2014 and held it in 7 quarters. The position peaked at $636K in Q3 2014. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

CenturyLink Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
CenturyLink Investment Management sold 3,805 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $626K.
CenturyLink Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 7 quarters.
CenturyLink Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $636K in Q3 2014.
159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on CenturyLink Investment Management's 13F filing for Q4 2016, filed 11 Jan 2017.